Hypoxic Gas Mixture ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
6. Parkinson disease
Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05214287 (ClinicalTrials.gov) | February 2022 | 28/12/2021 | Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease | An N-of-1 Double-blind Randomized Phase 1 Trial of the Safety and Feasibility of (Intermittent) Hypoxia Therapy in Parkinson's Disease | Parkinson Disease;Effect of Drug | Drug: Hypoxic Gas Mixture | Radboud University Medical Center | Michael J. Fox Foundation for Parkinson's Research | Recruiting | 18 Years | N/A | All | 20 | Phase 1/Phase 2 | Netherlands |